Exact Mass: 740.2944954000001
Exact Mass Matches: 740.2944954000001
Found 40 metabolites which its exact mass value is equals to given mass value 740.2944954000001
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Odevixibat
C37H48N4O8S2 (740.2913408000001)
C78276 - Agent Affecting Digestive System or Metabolism > C177170 - Ileal Bile Acid Transport Inhibitor A - Alimentary tract and metabolism > A05 - Bile and liver therapy > A05A - Bile therapy
(5S)-5-hydroxy-1,7-bis-(4-hydroxyphenyl)-3-heptanone-5-O-[2,6-bis-O-(beta-D-apiofuranosyl)-beta-D-glucopyranoside]
2alpha,7beta,9alpha,10beta-13alpha-pentaacetoxy-5alpha-cinnamoyloxy-4beta,20-epoxy-taxa-11-en-1beta-ol
8-methoxyhypophyllanthin-2a-O-beta-apiofuranosyl-(1->6)-O-beta-glucopyranoside
7-O-acetyl-5-O-benzoyl-13,15-dihydroxy-3,18-O-dinicotinoyl-14-oxo-lathyrane
C41H44N2O11 (740.2944954000001)
Odevixibat
C37H48N4O8S2 (740.2913408000001)
C78276 - Agent Affecting Digestive System or Metabolism > C177170 - Ileal Bile Acid Transport Inhibitor A - Alimentary tract and metabolism > A05 - Bile and liver therapy > A05A - Bile therapy
(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, hemihydrate
C36H42F2N6O9 (740.2981186000001)
D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(5r,6r)-9-[(2r,4r,5r,6r)-4-{[(2s,5s,6s)-5-{[(2s,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]-1,8-dihydroxy-5,6-dimethoxy-3-methyl-5,6-dihydrotetraphene-7,12-dione
(2s)-2-{[3-carboxy-3-({[(1s)-1-carboxy-5-[(2e)-n-hydroxy-3-phenylprop-2-enamido]pentyl]-c-hydroxycarbonimidoyl}methyl)-1,3-dihydroxypropylidene]amino}-6-[(2e)-n-hydroxy-3-phenylprop-2-enamido]hexanoic acid
(15r)-18-(4,5-dimethoxy-2-{[(1s)-5,6,7-trimethoxy-2-methyl-3,4-dihydro-1h-isoquinolin-1-yl]methyl}phenoxy)-11,19-dimethoxy-4,6-dioxa-13-azapentacyclo[10.7.1.0²,¹⁰.0³,⁷.0¹⁶,²⁰]icosa-1(20),2(10),3(7),8,11,16,18-heptaen-15-ol
C41H44N2O11 (740.2944954000001)
(1s,4r,5r,10r,12s,14r,15s,16r,18r,19s,20r,22s)-19-[(1s)-1-(acetyloxy)-2-methoxy-2-oxoethyl]-12-[(2r)-butan-2-yl]-5-(furan-3-yl)-15,16-dihydroxy-4,18,20-trimethyl-7-oxo-6,11,13,21-tetraoxaheptacyclo[10.8.1.1¹⁵,¹⁸.0¹,¹⁰.0⁴,⁹.0¹⁰,¹⁴.0¹⁶,²⁰]docos-8-en-22-yl (2z)-2-methylbut-2-enoate
(1s,2r,3r,4s,5s,7r,9s,10r,11s,12s,13s,15s)-15-(acetyloxy)-2-(benzoyloxy)-7,9-dihydroxy-1,5,9,12-tetramethyl-8-oxo-12-[(pyridine-3-carbonyloxy)methyl]tetracyclo[8.5.0.0³,⁷.0¹¹,¹³]pentadecan-4-yl pyridine-3-carboxylate
C41H44N2O11 (740.2944954000001)
2',7',9',10',13'-pentakis(acetyloxy)-1'-hydroxy-8',12',15',15'-tetramethylspiro[oxirane-2,4'-tricyclo[9.3.1.0³,⁸]pentadecan]-11'-en-5'-yl 3-phenylprop-2-enoate
methyl (1s,2r,3s,4r,7s,8e,10r,12s,13r,14r,16s,17r)-2,12,14,16-tetrakis(acetyloxy)-10-{[(3s)-3-(acetyloxy)butanoyl]oxy}-3-hydroxy-4,13,17-trimethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-ene-9-carboxylate
(1s,4r,5r,10r,12s,14r,15s,16r,18r,19s,20r,22s)-19-[(1s)-1-(acetyloxy)-2-methoxy-2-oxoethyl]-12-[(2r)-butan-2-yl]-5-(furan-3-yl)-15,16-dihydroxy-4,18,20-trimethyl-7-oxo-6,11,13,21-tetraoxaheptacyclo[10.8.1.1¹⁵,¹⁸.0¹,¹⁰.0⁴,⁹.0¹⁰,¹⁴.0¹⁶,²⁰]docos-8-en-22-yl (2e)-2-methylbut-2-enoate
15-(acetyloxy)-2-(benzoyloxy)-7,9-dihydroxy-1,5,9,12-tetramethyl-8-oxo-12-[(pyridine-3-carbonyloxy)methyl]tetracyclo[8.5.0.0³,⁷.0¹¹,¹³]pentadecan-4-yl pyridine-3-carboxylate
C41H44N2O11 (740.2944954000001)
(15r)-18-(4,5-dimethoxy-2-{[(1r)-5,6,7-trimethoxy-2-methyl-3,4-dihydro-1h-isoquinolin-1-yl]methyl}phenoxy)-11,19-dimethoxy-4,6-dioxa-13-azapentacyclo[10.7.1.0²,¹⁰.0³,⁷.0¹⁶,²⁰]icosa-1(20),2(10),3(7),8,11,16,18-heptaen-15-ol
C41H44N2O11 (740.2944954000001)
2-{[3-carboxy-3-({[1-carboxy-5-(n-hydroxy-3-phenylprop-2-enamido)pentyl]-c-hydroxycarbonimidoyl}methyl)-1,3-dihydroxypropylidene]amino}-6-(n-hydroxy-3-phenylprop-2-enamido)hexanoic acid
18-{4,5-dimethoxy-2-[(5,6,7-trimethoxy-2-methyl-3,4-dihydro-1h-isoquinolin-1-yl)methyl]phenoxy}-11,19-dimethoxy-4,6-dioxa-13-azapentacyclo[10.7.1.0²,¹⁰.0³,⁷.0¹⁶,²⁰]icosa-1(20),2(10),3(7),8,11,16,18-heptaen-15-ol
C41H44N2O11 (740.2944954000001)